Latest Canurta Therapeutics News & Updates

See the latest news and media coverage for Canurta Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Canurta Therapeutics

AI-backed multi-target botanical therapies developer

canurta.com
Headquarters
Mississauga, Canada
Founded year
2021
Company type
Private company
Number of employees
15–50

Last updated

Latest news about Canurta Therapeutics

In short: Canurta Therapeutics advanced its botanical drug pipeline, finalized a strategic stake sale to PharmaDrug, and launched the Polykye™ AI platform.

Company announcements

  • Canurta Therapeutics

    Canurta builds AI platform for adaptive botanical therapies

    The Polykye™ AI Platform accelerates discovery, optimization, and production of multi-target botanical drugs, enabling adaptive medicine.

  • Canurta Therapeutics

    Canurta Therapeutics announces preclinical GBM study

    Cannflavin B reduces tumor cell viability, migration, and invasion in vitro at low concentrations. Findings offer insights into cancer behavior.

  • Canurta Therapeutics

    Canurta Therapeutics evaluates CNR-401 for dogs with DM

    The clinical study, organized with Université de Montréal, targets dogs diagnosed with degenerative myelopathy due to SOD1 mutation. Contact the research team for eligibility.

  • Canurta Therapeutics

    Canurta Therapeutics enters strategic partnership with extractX Ltd

    The collaboration integrates Canurta's extraction methodologies into the enhanced Extract Mobile Lab Platform (EML 2.0), accelerating lab-to-commercial production.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Canurta Therapeutics

Track Canurta Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.